Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 1:53 PM
Ignite Modification Date: 2025-12-25 @ 12:43 PM
NCT ID: NCT02349295
Term: Adnexa uteri cyst
Organ System: Reproductive system and breast disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 22.0
Notes: None
Study: NCT02349295
Study Brief: A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 0 0 73 View
EG001 0 0 59 View
EG002 1 1 62 View
EG003 0 0 12 View
EG004 0 0 6 View
EG005 0 0 6 View
EG006 0 0 7 View
EG007 0 0 61 View
EG008 0 0 55 View
EG009 0 0 22 View
EG010 0 0 26 View
EG011 0 0 78 View
EG012 0 0 73 View
EG013 0 0 8 View